PANA-Surv: A Pathway-Guided Adaptive Neighborhood Augmentation Framework Using KEGG Pathways for Multi-Omics Cancer Prognosis
Open Access
Abstract
Background/Objectives: Integrating multi-omics data for cancer prognosis remains a challenging problem in bioinformatics because molecular profiles are high-dimensional, heterogeneous, and structured by incomplete biological relationships. Pathway databases provide biologically meaningful prior knowledge for modeling gene-level associations, but the sparsity and local incompleteness of pathway-derived networks often limit the performance of graph-based survival models. This study aimed to develop a pathway-guided framework for improving multi-omics survival prediction and identifying biologically relevant prognostic signals. Methods: We proposed PANA-Surv, a pathway-guided adaptive neighborhood augmentation framework for multi-omics cancer survival analysis. In this framework, KEGG pathways were used to construct gene graphs, and gene-level multi-omics profiles were encoded as node features. A conditional variational autoencoder module (PANA-VAE) was designed to enhance local representations through neighborhood reconstruction and adaptive weighting. The augmented features were then integrated into a graph convolutional survival model optimized with the Cox partial likelihood. Results: PANA-Surv was evaluated on 10 cancer cohorts from The Cancer Genome Atlas (TCGA). The proposed method achieved the highest mean concordance index (C-index) among all compared models and significantly outperformed Cox-EN, DeepSurv, GraphSurv, and LAGProg (all p < 0.01). Ablation analyses showed that both neighborhood reconstruction and adaptive weighting contributed to the observed performance gains, and KEGG-guided graph construction was more effective than alternative graph construction strategies. In a breast cancer (BRCA) case study, PANA-Surv identified 18 prognostic genes, including 12 genes supported by previous studies and 6 potentially novel candidates. Conclusions: These findings indicate that the integration of pathway prior knowledge with adaptive local feature enhancement can improve multi-omics survival modeling and support the identification of biologically relevant prognostic signals associated with cancer outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (2023YFB4503000)
- National Natural Science Foundation of China (62473129)
- National Natural Science Foundation of China (23JCYBJC00790)
This publication has 57 references indexed in Scilit:
- The role of biological macromolecules in the regulation of angiogenesis in glioblastoma: Focus on vascular growth factors, integrins, and extracellular matrix proteinsInternational Journal of Biological Macromolecules, 2025
- Breast cancer therapy in China: Introducing the Special CollectionCancer, 2024
- Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing studyThe Journal of Pathology: Clinical Research, 2024
- Impact of propofol versus sevoflurane anesthesia on molecular subtypes and immune checkpoints of glioma during surgeryHealth Science Reports, 2023
- Towards data augmentation in graph neural network: An overview and evaluationComputer Science Review, 2022
- HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastomaInternational Immunopharmacology, 2021
- ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to boneJournal of Bone Oncology, 2020
- KLK6‐regulated miRNA networks activate oncogenic pathways in breast cancer subtypesMolecular Oncology, 2016
- Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological gradesMedical Oncology, 2010
- RNA-seq: from technology to biologyCellular and Molecular Life Sciences, 2009